Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition

Jacobs, Bart; Van Oirbeek, Robin; Biesmans, Bart; Fieuws, Steffen; De Roock, Wendy; De Schutter, Jef; Humblet, Yves; Peeters, Marc; Van Cutsem, Eric; Tejpar, Sabine

doi:10.1016/S1359-6349(08)72024-X

Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition

Jacobs, Bart

;

Van Oirbeek, Robin

;

Biesmans, Bart

;

Fieuws, Steffen

;

Tejpar, Sabine

;et.al.

(2008) 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics — Location: (Switzerland) Geneva (24.October.2008)

Files

No attached file found for this publication.

Details

Authors

Jacobs, Bart
Author
Van Oirbeek, Robin
Author
Biesmans, Bart
Author
Fieuws, Steffen
Author
Humblet, YvesUCLouvain
Author
Tejpar, Sabine
Author

Affiliations

Citations

APA
Chicago
FWB

Jacobs, B., Van Oirbeek, R., Biesmans, B., Fieuws, S., De Roock, W., De Schutter, J., Humblet, Y., Peeters, M., Van Cutsem, E., & Tejpar, S. (2008). Amphiregulin and Epiregulin expression in primary colorectal cancer identifies a subgroup of patients that will respond to EGFR inhibition. EJC - Supplements, 6(12), 31. https://doi.org/10.1016/S1359-6349(08)72024-X (Original work published 2008)